Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes

Autor:	R. Dolezalova, Richard Ceska, Tomáš Štulc, Hana Krejci, Z. Kasalova
Rok vydání:	2005
Předmět:	Creatinine medicine.medical_specialty Homocysteine business.industry Urology Renal function Type 2 diabetes medicine.disease chemistry.chemical_compound chemistry Diabetes mellitus Medicine In patient Cardiology and Cardiovascular Medicine business Rosiglitazone medicine.drug
Zdroj:	Atherosclerosis. 183:367-368
ISSN:	0021-9150
DOI:	10.1016/j.atherosclerosis.2005.08.012
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e58f75d331f3eeeb41c2b04123b31fd4 https://doi.org/10.1016/j.atherosclerosis.2005.08.012 Zobrazit plný text záznamu Full Text from ScienceDirect